Clinical Trials Logo

Metastatic Cancer clinical trials

View clinical trials related to Metastatic Cancer.

Filter by:

NCT ID: NCT00003563 Completed - Metastatic Cancer Clinical Trials

Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases

Start date: August 1998
Phase: Phase 3
Study type: Interventional

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Gadolinium texaphyrin may increase the effectiveness of radiation therapy by making tumor cells more sensitive to radiation. It is not yet known whether giving gadolinium texaphyrin with radiation therapy is more effective than radiation therapy alone in treating brain metastases. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or without gadolinium texaphyrin in treating patients who have brain metastases.

NCT ID: NCT00003461 Completed - Metastatic Cancer Clinical Trials

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors

Start date: February 1998
Phase: Phase 1/Phase 2
Study type: Interventional

RATIONALE: Radiolabeled monoclonal antibodies can locate tumor cells and deliver radioactive tumor-killing substances to them without harming normal cells. This may be effective treatment for primary or metastatic brain tumors. PURPOSE: Phase I trial to study the effectiveness of radiolabeled monoclonal antibody therapy in treating patients with primary or metastatic brain tumors.

NCT ID: NCT00003433 Completed - Colorectal Cancer Clinical Trials

Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer

Start date: June 1998
Phase: Phase 1/Phase 2
Study type: Interventional

RATIONALE: Immunotherapy using CEA-treated white blood cells may help a person's body build an immune response to kill their tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of immunotherapy with CEA-treated white blood cells in treating patients with resected liver metastases from colon cancer.

NCT ID: NCT00003431 Completed - Colorectal Cancer Clinical Trials

Flt3L in Treating Patients With Metastatic Colorectal Cancer

Start date: June 1998
Phase: Phase 1
Study type: Interventional

RATIONALE: Flt3L may stimulate a person's immune system and help kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of flt3L given to patients before undergoing surgery to remove metastases from colorectal cancer.

NCT ID: NCT00003324 Completed - Metastatic Cancer Clinical Trials

Radiation Therapy With or Without Surgery in Treating Patients Who Have Brain Metastases

Start date: December 1997
Phase: N/A
Study type: Interventional

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells in a single high dose. Combining radiation therapy with surgery may be a more effective treatment for brain metastases. PURPOSE: Clinical trial to study the effectiveness of radiation therapy with or without surgery in treating patients who have brain metastases.

NCT ID: NCT00003320 Completed - Metastatic Cancer Clinical Trials

Radiation Therapy Following Surgery to Remove Brain Metastases

Start date: March 1997
Phase: N/A
Study type: Interventional

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Giving radiation therapy after surgery to remove brain metastases may decrease the amount of radiation required to treat brain metastases. PURPOSE: Pilot trial to study the effectiveness of radiation therapy following surgery to remove brain metastases.

NCT ID: NCT00003308 Completed - Ovarian Cancer Clinical Trials

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

Start date: February 2, 1999
Phase: Phase 2
Study type: Interventional

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase II trial to study the effectiveness of radiation therapy in treating patients with newly diagnosed brain metastases from kidney cancer, melanoma, or sarcoma.

NCT ID: NCT00003186 Completed - Colorectal Cancer Clinical Trials

Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer

Start date: April 1997
Phase: N/A
Study type: Interventional

RATIONALE: Diagnostic procedures, such as lymphography, may improve the identification of patients with metastatic colorectal cancer. PURPOSE: Clinical trial to study the effectiveness of lymphography in determining the presence or absence of metastatic colorectal cancer in patients.

NCT ID: NCT00003162 Completed - Breast Cancer Clinical Trials

Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer

Start date: February 1998
Phase: Phase 3
Study type: Interventional

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which radiation therapy regimen is more effective for bone metastases. PURPOSE: Randomized phase III trial to compare different radiation therapy regimens in treating patients who have bone metastases from breast or prostate cancer.

NCT ID: NCT00002997 Completed - Colorectal Cancer Clinical Trials

Cryosurgery in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

Start date: February 4, 1998
Phase: Phase 2
Study type: Interventional

RATIONALE: Cryosurgery for liver metastases may have fewer side effects and improve recovery. PURPOSE: Phase II trial to study the effectiveness of cryosurgery for patients with unresectable liver metastases from colorectal cancer.